SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-106979
Filing Date
2024-04-23
Accepted
2024-04-23 16:06:27
Documents
6
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A d703012ddef14a.htm DEF 14A 343339
2 GRAPHIC g703012g40m34.jpg GRAPHIC 25465
3 GRAPHIC g703012g64q82.jpg GRAPHIC 36160
4 GRAPHIC g703012g70j10.jpg GRAPHIC 15313
5 GRAPHIC g703012g88d89.jpg GRAPHIC 136063
6 GRAPHIC g703012g95k09.jpg GRAPHIC 95353
  Complete submission text file 0001193125-24-106979.txt   762440
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38938 | Film No.: 24864857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)